Chair Kevin Warsh Will Face Two Tests in His First 100 Days
As a new Fed chair, chair kevin warsh will confront two high-stakes tests in just 100 days. One test centers on polit...
What To Consider When Using A Balance Transfer Card
Thinking of using a balance transfer card? Here are key considerations to help you make informed decisions and manage your debt.
23,841 articles
Energy Stocks That Stand the Test of Time for Investors
The energy landscape is famous for cycles that can rattle even seasoned investors. This guide explains how to spot en...
Berkshire Hathaway's Greg Abel Bets Big on AI Winners Ahead
Berkshire Hathaway's Greg Abel could be quietly steering a strategic tilt toward AI-enabled winners. This deep dive e...
Occidental Petroleum Stock Rocketed: February Rally Explained
In February, Occidental Petroleum’s stock surged nearly 17%, powered by higher oil prices and strong earnings signals...
What Happens Year with IRA RMD Timing in 2026 Case
In 2026, retirees consider monthly RMDs versus lump-sum year-end pulls as market volatility tests tax and cash-flow p...
Artificial Intelligence (AI) Stock: Institutions Load Up 2026
Institutional buyers are quietly backing a select set of artificial intelligence (ai) stock for 2026. This deep dive ...
Safe Amgen's Dividend? A Practical Investor's Guide
Amgen's dividend has powered income-focused portfolios for years, but regulatory and pricing challenges raise questio...
Karat Packaging Stock Soared: A Closer Look at the Rally
When a packaging company posts stronger results, investors take notice. This piece explains why karat packaging stock...
Qualcomm: Which Stock Better for AI PC Growth in 2026
Investors are weighing AMD and QUALCOMM in the AI PC upgrade cycle. This guide breaks down which stock shows a strong...
Reasons Give Cruise Line Stocks a Second Wind in 2026
Two clear reasons reasons give cruise line stocks may rebound as travel demand returns and operators strengthen finan...
Chair Kevin Warsh Just Shifts Fed Policy, Markets Watch
Wall Street watches a hypothetical shift as chair kevin warsh just signals a new, discipline-focused approach at the ...
This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status